FDA Update: Ongoing Essure Surveillance

FDA Update: Ongoing Essure Surveillance

Source: 
Medical Devices and Diagnostics Industry
snippet: 

Just over a year after Bayer stopped selling its Essure birth control implant in the United States, the company's mandatory post-market surveillance study on the controversial device has ended.